Preparation of magnetic resonance contrast agents activated by β-galactosidase

Nature Protocols

Volumn 3, Issue 3, 2008, Pages 341-350

  Urbanczyk Pearson, L M Lauren M ^a   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BUFFER; CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ARTICLE; CHEMICAL REACTION KINETICS; DIASTEREOISOMER; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENZYME ASSAY; METALLATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PRIORITY JOURNAL; RACEMIC MIXTURE; ROOM TEMPERATURE; STRUCTURE ANALYSIS;

BETA-GALACTOSIDASE; CHEMISTRY, ORGANIC; EPOXY COMPOUNDS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 40649095493     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.529     Document Type: Article

References (15)

1. Spergel, D.J. Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studies. Prog. Neurobiol. 2001; 63, 673-686.
2. Alauddin, M.M., Louie, A.Y., Shahinian, A.M., Meade, T.J. & Conti, P.S. Receptor mediated uptake of a radiolabeled contrast agent sensitive to β-galactosidase activity. Nucl. Med. Biol. 2003; 30, 261-265.
3. Louie, A.Y. et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 2000; 18, 321-325.
4. Moats, R.A., Fraser, S.E. & Meade, T.J. A 'smart' magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem. 1997; 36, 726-728.
5. Caravan, P., Ellison, J.J., McMurry, T.J. & Lauffer, R.B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 1999; 99, 2293-2352.
6. Jacobs, R.E. & Fraser, S.E. Magnetic resonance microscopy of embryonic cell lineages and movements. Science 1994; 263, 681-684.
7. Mellin, A.F. et al. Three dimensional magnetic resonance microangiography of rat neurovasculature. Magn. Reson. Med. 1994; 32, 199-205.
8. Merbach, A.E. & Toth, E. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging (John Wiley and Sons Ltd., West Sussex, 2001).
9. Lauffer, R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem. Rev. 1987; 87 901-927.
10. Bertini, I. & Luchinat, C. NMR of Paramagnetic Molecules in Biological Systems (Benjamin/Cummings, Menlo Park, California, 1986).
11. Koenig, S.H. & Keller, K.E. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn. Reson. Med. 1995; 34 227-233.
12. Peters, J.A., Huskens, J. & Raber, D.J. Lanthanide induced shifts and relaxation rate enhancements. Prog. Nucl. Magn. Reson. Spectrosc. 1996; 28, 283-350.
13. Urbanczyk-Pearson, L.M. et al. Mechanistic investigation of β-galactosidase-activated MR contrast agents. Inorg. Chem. 2008; 47, 56-68.
14. White, D.E. & Jacobsen, E.N. New oligomeric catalyst for the hydrolytic kinetic resolution of terminal epoxides under solvent-free conditions. Tetrahedron Asymmetry 2003; 14, 3633-3638.
15. Ghosh, I., Zeng, H. & Kishi, Y. Application of chiral lanthanide shift reagents for assignment of absolute configuration of alcohols. Org. Lett. 2004; 6, 4715-4718.